Jay Flatley has overseen tremendous growth at life science tools company Illumina in the past decade.

FORBES: Magazine Article

If the cost does drop, the market "verges on being insatiable, " says Jay Flatley, chief executive of Illumina, the leading maker of DNA sequencers.

FORBES: Why You Can't Have Your $1,000 Genome

Illumina Chief Executive Jay Flatley claims the PGM poses no threat.

FORBES: Companies, People, Ideas

Illumina of San Diego, the leading maker of DNA sequencers, runs a service business that chief executive Jay Flatley has said has been seeing mainly infants and cancer patients.

FORBES: Sequencing A Child's DNA -- And Convincing An Insurance Company To Pay

With the case of Illumina, while Jay Flatley is without question an outstanding CEO, much credit is also due to the revolutionary microarray-technology that enabled Illumina to grow on the turf of Affymetrix.

FORBES: Biotech's Biggest Winner

Illumina chief executive Jay Flatley has showed off an app that allowed him to read his DNA variants on a iPhone, and the initial customers to pay Illumina to sequence their DNA got their genomes on Macintosh computers.

FORBES: Ion Torrent Gives Its DNA-Sequencing Box A Boost